Selected research
Industry Research
Biomedical Polyurethane Industry Research Report 2026
Market perspective
The global Biomedical Polyurethane market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
The North America market for Biomedical Polyurethane is forecast to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.
The Europe market for Biomedical Polyurethane is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.
Read the full market overview
The Asia Pacific market for Biomedical Polyurethane is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.
Leading global manufacturers of Biomedical Polyurethane include , among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report quantifies the global Biomedical Polyurethane market in revenue (US$ million) and, where applicable, sales volume (Tons), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of types and applications, harmonizes vendor attribution, and presents comparable time series by company, type, application, and region/country, including indicative price bands (US$/Tons) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for manufacturers, new entrants, channel partners, and investors; the report also reviews technology shifts and notable product introductions relevant to Biomedical Polyurethane.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Biomedical Polyurethane Market by Company
Mitsubishi Chemical
BASF
DSM
Covestro
Lubrizol
Recticel
LANXESS
INOAC
WITPFoam
Rogers Corporation
Wanhua Chemical
Biomedical Polyurethane Segment by Type
Polyurethane Coated
Polyurethane Foam
Biomedical Polyurethane Segment by Application
Orthopaedics
Cardiovascular
Thoracic Surgery
Other
Biomedical Polyurethane Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Colombia
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Biomedical Polyurethane market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Biomedical Polyurethane and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Biomedical Polyurethane.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Biomedical Polyurethane manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Biomedical Polyurethane by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Biomedical Polyurethane in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Polyurethane Coated
- Polyurethane Foam
Applications
- Orthopaedics
- Cardiovascular
- Thoracic Surgery
- Other
Companies covered
- Mitsubishi Chemical
- BASF
- DSM
- Covestro
- Lubrizol
- Recticel
- LANXESS
- INOAC
- WITPFoam
- Rogers Corporation
- Wanhua Chemical
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Biomedical Polyurethane by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.2.2 Polyurethane Coated
- 2.2.3 Polyurethane Foam
- 2.3 Biomedical Polyurethane by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Orthopaedics
- 2.3.3 Cardiovascular
- 2.3.4 Thoracic Surgery
- 2.3.5 Other
- 2.4 Global Market Growth Prospects
- 2.4.1 Global Biomedical Polyurethane Production Value Estimates and Forecasts (2021-2032)
- 2.4.2 Global Biomedical Polyurethane Production Capacity Estimates and Forecasts (2021-2032)
- 2.4.3 Global Biomedical Polyurethane Production Estimates and Forecasts (2021-2032)
- 2.4.4 Global Biomedical Polyurethane Market Average Price (2021-2032)
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Biomedical Polyurethane Production by Manufacturers (2021-2026)
- 3.2 Global Biomedical Polyurethane Production Value by Manufacturers (2021-2026)
- 3.3 Global Biomedical Polyurethane Average Price by Manufacturers (2021-2026)
- 3.4 Global Biomedical Polyurethane Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Biomedical Polyurethane Key Manufacturers, Manufacturing Sites & Headquarters
- 3.6 Global Biomedical Polyurethane Manufacturers, Product Type & Application
- 3.7 Global Biomedical Polyurethane Manufacturers Established Date
- 3.8 Global Biomedical Polyurethane Market CR5 and HHI
- 3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 Mitsubishi Chemical
- 4.1.1 Mitsubishi Chemical Biomedical Polyurethane Company Information
- 4.1.2 Mitsubishi Chemical Biomedical Polyurethane Business Overview
- 4.1.3 Mitsubishi Chemical Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.1.4 Mitsubishi Chemical Product Portfolio
- 4.1.5 Mitsubishi Chemical Recent Developments
- 4.2 BASF
- 4.2.1 BASF Biomedical Polyurethane Company Information
- 4.2.2 BASF Biomedical Polyurethane Business Overview
- 4.2.3 BASF Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.2.4 BASF Product Portfolio
- 4.2.5 BASF Recent Developments
- 4.3 DSM
- 4.3.1 DSM Biomedical Polyurethane Company Information
- 4.3.2 DSM Biomedical Polyurethane Business Overview
- 4.3.3 DSM Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.3.4 DSM Product Portfolio
- 4.3.5 DSM Recent Developments
- 4.4 Covestro
- 4.4.1 Covestro Biomedical Polyurethane Company Information
- 4.4.2 Covestro Biomedical Polyurethane Business Overview
- 4.4.3 Covestro Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.4.4 Covestro Product Portfolio
- 4.4.5 Covestro Recent Developments
- 4.5 Lubrizol
- 4.5.1 Lubrizol Biomedical Polyurethane Company Information
- 4.5.2 Lubrizol Biomedical Polyurethane Business Overview
- 4.5.3 Lubrizol Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.5.4 Lubrizol Product Portfolio
- 4.5.5 Lubrizol Recent Developments
- 4.6 Recticel
- 4.6.1 Recticel Biomedical Polyurethane Company Information
- 4.6.2 Recticel Biomedical Polyurethane Business Overview
- 4.6.3 Recticel Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.6.4 Recticel Product Portfolio
- 4.6.5 Recticel Recent Developments
- 4.7 LANXESS
- 4.7.1 LANXESS Biomedical Polyurethane Company Information
- 4.7.2 LANXESS Biomedical Polyurethane Business Overview
- 4.7.3 LANXESS Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.7.4 LANXESS Product Portfolio
- 4.7.5 LANXESS Recent Developments
- 4.8 INOAC
- 4.8.1 INOAC Biomedical Polyurethane Company Information
- 4.8.2 INOAC Biomedical Polyurethane Business Overview
- 4.8.3 INOAC Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.8.4 INOAC Product Portfolio
- 4.8.5 INOAC Recent Developments
- 4.9 WITPFoam
- 4.9.1 WITPFoam Biomedical Polyurethane Company Information
- 4.9.2 WITPFoam Biomedical Polyurethane Business Overview
- 4.9.3 WITPFoam Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.9.4 WITPFoam Product Portfolio
- 4.9.5 WITPFoam Recent Developments
- 4.10 Rogers Corporation
- 4.10.1 Rogers Corporation Biomedical Polyurethane Company Information
- 4.10.2 Rogers Corporation Biomedical Polyurethane Business Overview
- 4.10.3 Rogers Corporation Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.10.4 Rogers Corporation Product Portfolio
- 4.10.5 Rogers Corporation Recent Developments
- 4.11 Wanhua Chemical
- 4.11.1 Wanhua Chemical Biomedical Polyurethane Company Information
- 4.11.2 Wanhua Chemical Biomedical Polyurethane Business Overview
- 4.11.3 Wanhua Chemical Biomedical Polyurethane Production Capacity, Value and Gross Margin (2021-2026)
- 4.11.4 Wanhua Chemical Product Portfolio
- 4.11.5 Wanhua Chemical Recent Developments
5 Global Biomedical Polyurethane Production by Region
- 5.1 Global Biomedical Polyurethane Production Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.2 Global Biomedical Polyurethane Production by Region: 2021-2032
- 5.2.1 Global Biomedical Polyurethane Production by Region: 2021-2026
- 5.2.2 Global Biomedical Polyurethane Production Forecast by Region (2027-2032)
- 5.3 Global Biomedical Polyurethane Production Value Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 5.4 Global Biomedical Polyurethane Production Value by Region: 2021-2032
- 5.4.1 Global Biomedical Polyurethane Production Value by Region: 2021-2026
- 5.4.2 Global Biomedical Polyurethane Production Value Forecast by Region (2027-2032)
- 5.5 Global Biomedical Polyurethane Market Price Analysis by Region (2021-2026)
- 5.6 Global Biomedical Polyurethane Production and Value, YOY Growth
- 5.6.1 North America Biomedical Polyurethane Production Value Estimates and Forecasts (2021-2032)
- 5.6.2 Europe Biomedical Polyurethane Production Value Estimates and Forecasts (2021-2032)
- 5.6.3 China Biomedical Polyurethane Production Value Estimates and Forecasts (2021-2032)
- 5.6.4 Japan Biomedical Polyurethane Production Value Estimates and Forecasts (2021-2032)
6 Global Biomedical Polyurethane Consumption by Region
- 6.1 Global Biomedical Polyurethane Consumption Estimates and Forecasts by Region: 2021 VS 2025 VS 2032
- 6.2 Global Biomedical Polyurethane Consumption by Region (2021-2032)
- 6.2.1 Global Biomedical Polyurethane Consumption by Region: 2021-2026
- 6.2.2 Global Biomedical Polyurethane Forecasted Consumption by Region (2027-2032)
- 6.3 North America
- 6.3.1 North America Biomedical Polyurethane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.3.2 North America Biomedical Polyurethane Consumption by Country (2021-2032)
- 6.3.3 United States
- 6.3.4 Canada
- 6.3.5 Mexico
- 6.4 Europe
- 6.4.1 Europe Biomedical Polyurethane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.4.2 Europe Biomedical Polyurethane Consumption by Country (2021-2032)
- 6.4.3 Germany
- 6.4.4 France
- 6.4.5 U.K.
- 6.4.6 Italy
- 6.4.7 Russia
- 6.4.8 Spain
- 6.4.9 Netherlands
- 6.4.10 Switzerland
- 6.4.11 Sweden
- 6.4.12 Poland
- 6.5 Asia Pacific
- 6.5.1 Asia Pacific Biomedical Polyurethane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.5.2 Asia Pacific Biomedical Polyurethane Consumption by Country (2021-2032)
- 6.5.3 China
- 6.5.4 Japan
- 6.5.5 South Korea
- 6.5.6 India
- 6.5.7 Australia
- 6.5.8 Taiwan
- 6.5.9 Southeast Asia
- 6.6 South America, Middle East & Africa
- 6.6.1 South America, Middle East & Africa Biomedical Polyurethane Consumption Growth Rate by Country: 2021 VS 2025 VS 2032
- 6.6.2 South America, Middle East & Africa Biomedical Polyurethane Consumption by Country (2021-2032)
- 6.6.3 Brazil
- 6.6.4 Argentina
- 6.6.5 Chile
- 6.6.6 Turkey
- 6.6.7 GCC Countries
7 Segment by Type
- 7.1 Global Biomedical Polyurethane Production by Type (2021-2032)
- 7.1.1 Global Biomedical Polyurethane Production by Type (2021-2032) & (Tons)
- 7.1.2 Global Biomedical Polyurethane Production Market Share by Type (2021-2032)
- 7.2 Global Biomedical Polyurethane Production Value by Type (2021-2032)
- 7.2.1 Global Biomedical Polyurethane Production Value by Type (2021-2032) & (US$ Million)
- 7.2.2 Global Biomedical Polyurethane Production Value Market Share by Type (2021-2032)
- 7.3 Global Biomedical Polyurethane Price by Type (2021-2032)
8 Segment by Application
- 8.1 Global Biomedical Polyurethane Production by Application (2021-2032)
- 8.1.1 Global Biomedical Polyurethane Production by Application (2021-2032) & (Tons)
- 8.1.2 Global Biomedical Polyurethane Production Market Share by Application (2021-2032)
- 8.2 Global Biomedical Polyurethane Production Value by Application (2021-2032)
- 8.2.1 Global Biomedical Polyurethane Production Value by Application (2021-2032) & (US$ Million)
- 8.2.2 Global Biomedical Polyurethane Production Value Market Share by Application (2021-2032)
- 8.3 Global Biomedical Polyurethane Price by Application (2021-2032)
9 Value Chain and Sales Channels Analysis of the Market
- 9.1 Biomedical Polyurethane Value Chain Analysis
- 9.1.1 Biomedical Polyurethane Key Raw Materials
- 9.1.2 Raw Materials Key Suppliers
- 9.1.3 Biomedical Polyurethane Production Mode & Process
- 9.2 Biomedical Polyurethane Sales Channels Analysis
- 9.2.1 Direct Comparison with Distribution Share
- 9.2.2 Biomedical Polyurethane Distributors
- 9.2.3 Biomedical Polyurethane Customers
10 Global Biomedical Polyurethane Analyzing Market Dynamics
- 10.1 Biomedical Polyurethane Industry Trends
- 10.2 Biomedical Polyurethane Industry Drivers
- 10.3 Biomedical Polyurethane Industry Opportunities and Challenges
- 10.4 Biomedical Polyurethane Industry Restraints
11 Report Conclusion
12 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst